findmyKOL

Steven Gedde, MD

Enriched profile

Professor of Ophthalmology; John G. Clarkson Chair in Ophthalmology; Executive Vice Chair and Vice Chair of Education, Bascom Palmer Eye Institute · Bascom Palmer Eye Institute

ORCIDNPI
Region🇺🇸 Miami, FL · Southeast · United StatesSpecialtyOphthalmologyFocusGlaucoma
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceverified 2026Payments2024–2025NIH fundingNone on fileWhy? →

Steven Gedde is Professor of Ophthalmology; John G. Clarkson Chair in Ophthalmology; Executive Vice Chair and Vice Chair of Education, Bascom Palmer Eye Institute at Bascom Palmer Eye Institute. OpenAlex indexes 206 publications with 11,184 citations (h-index 41); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Steven J. Gedde, MD, is Professor of Ophthalmology at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. The public record shows 206 publications with 11,184 citations (h-index 41), centered on Glaucoma. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 2 companies.

  • Top research focus: Glaucoma
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Glaucoma2 trialsComa2 trials

Research focus

OpenAlex concept fingerprint
Glaucoma

Works with

trial sponsors and companies reporting payments
University of MiamiClinical trials2Industry paymentsAlcon Vision LLCClinical trialsIndustry payments1Sight Sciences, Inc.Clinical trialsIndustry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
206publications

Distinct works indexed by OpenAlex, matched via ORCID.

11,184citations

Total citations across indexed works.

41h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
2companies · 2024–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

2 companies reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    88.9%
    Prostaglandin Analog38.1%
    Latanoprost82%Travoprost9%Lumigan6%Zioptan2%Tafluprost2%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor24.2%
    Dorzolamide-Timolol70%Dorzolamide Hcl20%Brinzolamide7%Acetazolamide2%Acetazolamide Er2%
    Part D<11 patients
  • Cardiovascular

    8.3%
    Beta blocker8.3%
    Timolol Maleate100%
    Part D<11 patients
  • Cancer & immunology

    1.1%
    Calcineurin inhibitor1.1%
    Restasis56%Restasis Multidose44%
    Part D<11 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/steven-gedde-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Steven-Gedde

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    news.med.miami.edu/bascom-palmer-eye-institutes-dr-steven-gedde-appointed-ceo-of-the-american-board-of-ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.miami.edu
  • Other

    news.med.miami.edu/renowned-bascom-palmer-glaucoma-expert-leads-the-american-glaucoma-society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.miami.edu
  • Other

    aao.org/about/awards/straatsma/steven-gedde

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aao.org
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Glaucoma Fellowship

    Bascom Palmer Eye Institute

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu
  • Ophthalmology Residency

    Wills Eye Hospital (1995), Chief Resident

    1995
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu
  • MD

    Vanderbilt University School of Medicine

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu
  • Board Certified

    Ophthalmology (American Board of Ophthalmology)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bascompalmer-doctors.umiamihealth.org

Editorial & leadership roles

journal and society appointments
  • President

    American Glaucoma Society

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →visionmonday.com
  • Chair

    Glaucoma Preferred Practice Pattern Panel, American Academy of Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bascompalmer-doctors.umiamihealth.org
  • Former Editorial Board member: Ophthalmology

    Journal of Academic Ophthalmology, EyeNet, Ocular Surgery News, Ophthalmology Management, EyeWorld

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bascompalmer-doctors.umiamihealth.org
4 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
7 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Incoming Chief Executive Officer

    American Board of Ophthalmology

    2027
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.miami.edu
  • Director

    Global Center for Ophthalmic Education, Bascom Palmer Eye Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.miami.edu

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.